Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2000
08/03/2000CA2356299A1 Acetylenic .alpha.-amino acid-based sulfonamide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000CA2355735A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
08/02/2000EP1023906A1 Potentiator for antibody against lymphoid tumor
08/02/2000EP1023904A2 Adjuvants for use in vaccines
08/02/2000EP1023319A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus
08/02/2000EP1023311A1 Novel bacterial polypeptides and polynucleotides
08/02/2000EP1023308A1 Inhibitors of nucleoside metabolism
08/02/2000EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000EP1023266A2 Process for making diaryl pyridines useful as cox-2 inhibitors
08/02/2000EP1023263A1 Novel vitamin d analogues
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023080A1 Ligand binding site of rage and uses thereof
08/02/2000EP1023067A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP0885229B1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon
08/02/2000EP0682528B1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane
08/02/2000CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000CN1261886A Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperdylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine
08/02/2000CN1261885A 2-substituted 4,5-diaryl imidazoles
08/02/2000CN1261881A 6-azauracil derivatives as IL-5 inhibitors
08/02/2000CN1261880A Inhibitors of farnesyl protein transferase
08/02/2000CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors
08/02/2000CN1261799A Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
08/02/2000CN1261797A Self-emulsifying formulation forlipophilic compounds
08/02/2000CN1261796A Self-emulsifying formulation for lipophilic compounds
08/02/2000CN1261795A Compounds and methods
08/02/2000CN1261790A Self-emulsifying formulation for lipophilic compounds
08/02/2000CN1055093C Glucosamine disaccharides, its preparation and use, and pharmaceutical composition comprising same
08/01/2000US6096904 Discodermolides
08/01/2000US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
08/01/2000US6096872 Viral clearance process
08/01/2000US6096871 Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
08/01/2000US6096777 Method for inhibiting the expression of Fas
08/01/2000US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding
08/01/2000US6096753 Substituted pyrimidinone and pyridone compounds and methods of use
08/01/2000US6096749 Pyrrolopyrimidine derivatives having pharmacological activity
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096739 Treatment for CNS injuries
08/01/2000US6096737 Treatment of multiple sclerosis (MS) and other demyelinating conditions using lofepramine in combination with L-phenylalanine, tyrosine or tryptophan and possibly a vitamin B12 compound
08/01/2000US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents
08/01/2000US6096520 Brain glycogen phosphorylase cancer antigen
08/01/2000US6096515 Nucleotide sequence of polypeptide associated with transcription factor, nuclear factor of activated t cells; hybridization probes; polymerase chain reaction primers;screening for immunomodulators; therapy of related
08/01/2000US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics
08/01/2000US6096314 Peptides and pharmaceutical compositions comprising them
08/01/2000US6096313 Immunology using peptides of amino acid sequences
08/01/2000US6096308 Human protein kinase and kinase inhibitors
08/01/2000US6096305 Receptor that binds IL-17
08/01/2000CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
08/01/2000CA2178760C Hiv protease inhibitors
08/01/2000CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
08/01/2000CA2151618C Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
08/01/2000CA2019335C Phenylalkan (en)oic acids
07/2000
07/29/2000CA2290078A1 Erysipelothrix rhusiopathiae antigens and vaccine compositions
07/29/2000CA2260397A1 Method of converting rendered triglyceride oil from marine sources into bland, stable food oil
07/27/2000WO2000043511A1 Polypeptide
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043419A2 Exocytosis pathway proteins and methods of use
07/27/2000WO2000043415A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043394A1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
07/27/2000WO2000043393A1 Novel angiogenesis inhibitors
07/27/2000WO2000043384A1 Aromatic heterocyclic compounds as antiinflammatory agents
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response
07/27/2000WO2000043030A1 Method of suppressing ongoing acute allograff rejection
07/27/2000WO2000043023A1 Pharmaceutical composition with adhesion molecule expression regulating activity
07/27/2000WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000043018A1 Medicinal compositions
07/27/2000WO2000043016A1 DICARBA-closo-DODECABORANE DERIVATIVES
07/27/2000WO2000042989A2 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
07/27/2000WO2000042856A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone
07/27/2000WO2000042852A1 Compounds and methods
07/27/2000WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases
07/27/2000WO2000023592A3 Minimal promoters and uses thereof
07/27/2000WO2000023567A3 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors
07/27/2000WO2000023068A3 Fumaric acid microtablets
07/27/2000WO2000018915A3 Membrane-associated organizational proteins
07/27/2000WO2000011171A3 Human rna-associated proteins
07/27/2000WO2000009159A9 Compositions of cpg and saponin adjuvants and methods thereof
07/27/2000WO2000008202A9 3-methylidenyl-2-indolinone modulators of protein kinase
07/27/2000CA2361272A1 33 human secreted proteins
07/27/2000CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response
07/27/2000CA2359680A1 Kinase inhibitors
07/27/2000CA2359482A1 Organoprotective solutions
07/27/2000CA2359145A1 Exocytosis pathway proteins and methods of use
07/27/2000CA2359114A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359113A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2359112A1 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000CA2358963A1 Cancer-associated proteins
07/27/2000CA2358899A1 Polypeptide
07/27/2000CA2358584A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000CA2356349A1 Novel angiogenesis inhibitors
07/27/2000CA2355168A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/26/2000EP1022338A2 Viral vaccines
07/26/2000EP1022278A1 Tetracyclical derivatives from pyrimidine
07/26/2000EP1021540A1 Human progesterone receptor complex p23-like protein
07/26/2000EP1021537A1 T cell receptor-associated molecules (trams) and methods of use therefor
1 ... 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 ... 1172